Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • ELECTRON MICROSCOPY [undo]
  • Laboratorul de microbiologie alimentară [undo]
  • Κλινική εξέταση [undo]
  • Σωματικό βάρος και ύψος [undo]
  • Increased elimination of cholesterol [undo]
  • Call intensive care [undo]
  • Node 2: Discuss Maria's feelings and concerns [undo]
  • Επιπλέον πληροφορίες [undo]
  • Θα κάνουμε ένα stick ούρων. [undo]
  • Ignore the emotional expression. [undo]
  • Προγεννητικός έλεγχος- αμνιοπαρακέντηση [undo]
  • Επανεκτίμηση από παιδίατρο [undo]
  • Πορεία νόσου [undo]
  • Eργαστηριακά [undo]
  • Θα στείλουμε Γενική Ούρων και Καλλιέργεια, καθώς και αιματολογικές εξετάσεις. [undo]
  • A atividade é cozinhar. [undo]
  • METABOLISMO DE LAS ENZIMAS CELULARES [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21112
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway